FDA.reportPublic FDA data

Application 211038

Type
ANDA
Sponsor
SUVEN LIFE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CALCIUM ACETATECALCIUM ACETATECAPSULE;ORAL667MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16571-813Calcium AcetateCalcium AcetateRising Pharma Holdings, Inc.ANDACurrent
16571-813Calcium AcetateCalcium AcetateRising Pharma Holdings, Inc.ANDACurrent
16571-813Calcium AcetateCalcium AcetateRising Pharma Holdings, Inc.ANDACurrent
24689-793Calcium AcetateCalcium AcetateApnar PharmaANDACurrent
24689-793Calcium AcetateCalcium AcetateApnar PharmaANDACurrent
24689-793Calcium AcetateCalcium AcetateApnar PharmaANDACurrent
24689-793Calcium AcetateCalcium AcetateApnar PharmaANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Life Sciences LtdANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Life Sciences LtdANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Life Sciences LtdANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Life Sciences LtdANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Pharmaceuticals LimitedANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Pharmaceuticals LimitedANDACurrent
68022-0119Calcium AcetateCalcium Acetate Capsules 667 mgSuven Pharmaceuticals LimitedANDACurrent